Pediatrix Medical Group Inc (FRA:PDC)

€ 13.6 0.3 (2.26%) Market Cap: 1.12 Bil Enterprise Value: 1.57 Bil PE Ratio: 0 PB Ratio: 1.60 GF Score: 64/100

Q3 2024 Pediatrix Medical Group Inc Earnings Call Transcript
Nov 01, 2024

€11.5 (+2.68%)

Earnings
Q2 2024 Pediatrix Medical Group Inc Earnings Call Transcript
Aug 06, 2024

€6.8 (-4.90%)

Earnings
Q1 2024 Pediatrix Medical Group Inc Earnings Call Transcript
May 07, 2024

€8.5

Earnings
Q4 2023 Pediatrix Medical Group Inc Earnings Call Transcript
Feb 20, 2024

€8.45

Earnings
Q3 2023 Pediatrix Medical Group Inc Earnings Call Transcript
Nov 02, 2023

€10.4

Earnings
Q2 2023 Pediatrix Medical Group Inc Earnings Call Transcript
Aug 03, 2023

€12.5 (+1.63%)

Earnings
Pediatrix Medical Group Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023
Q1 2023 Pediatrix Medical Group Inc Earnings Call Transcript
May 02, 2023

€12.9 (+0.78%)

Earnings
Q4 2022 Pediatrix Medical Group Inc Earnings Call Transcript
Feb 17, 2023

€14 (+1.45%)

Earnings
Q3 2022 Pediatrix Medical Group Inc Earnings Call Transcript
Nov 03, 2022

€15.5 (-20.92%)

Earnings
Q2 2022 Pediatrix Medical Group Inc Earnings Call Transcript
Aug 04, 2022

€21 (-6.25%)

Earnings
Q1 2022 MEDNAX Inc Earnings Call Transcript
Apr 28, 2022

€19.7 (-7.08%)

Earnings
Q4 2021 MEDNAX Inc Earnings Call Transcript
Feb 17, 2022

€21.8 (-1.80%)

Earnings
MEDNAX Inc at Bank of America Leveraged Finance Conference (Virtual) Transcript
Nov 30, 2021
MEDNAX Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2021
Q3 2021 MEDNAX Inc Earnings Call Transcript
Oct 28, 2021

€23.4 (-0.85%)

Earnings
MEDNAX Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2021
Q2 2021 MEDNAX Inc Earnings Call Transcript
Aug 06, 2021

€25.4 (+0.79%)

Earnings
MEDNAX Inc Annual Shareholders Meeting Transcript
May 12, 2021
Q1 2021 MEDNAX Inc Earnings Call Transcript
May 07, 2021

€25.4 (+14.41%)

Earnings
Q4 2020 MEDNAX Inc Earnings Call Transcript
Feb 18, 2021

€22 (-4.35%)

Earnings
Q3 2020 MEDNAX Inc Earnings Call Transcript
Nov 06, 2020

€11.8 (+3.51%)

Earnings
MEDNAX Inc Annual Shareholders Meeting Transcript
Sep 09, 2020
Q2 2020 MEDNAX Inc Earnings Call Transcript
Jul 30, 2020

€17.1 (+1.18%)

Earnings
MEDNAX Inc Business Update Conference Call/Webcast Transcript
Jun 05, 2020
Q1 2020 MEDNAX Inc Earnings Call Transcript
May 07, 2020

€12.7 (+5.83%)

Earnings
Q4 2019 MEDNAX Inc Earnings Call Transcript
Feb 20, 2020

€24.4 (-0.81%)

Earnings
MEDNAX Inc at Bank of America Merrill Lynch Leveraged Finance Conference Transcript
Dec 03, 2019
MEDNAX Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 13, 2019
Q3 2019 MEDNAX Inc Earnings Call Transcript
Nov 01, 2019

€19.5 (-2.01%)

Earnings
Q2 2019 MEDNAX Inc Earnings Call Transcript
Aug 01, 2019

€21.99 (+0.92%)

Earnings
MEDNAX Inc at Jefferies Healthcare Conference Transcript
Jun 04, 2019
MEDNAX Inc at UBS Global Healthcare Conference Transcript
May 20, 2019
MEDNAX Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
Q1 2019 MEDNAX Inc Earnings Call Transcript
May 02, 2019

€24.95 (+0.48%)

Earnings
MEDNAX Inc at Raymond James Institutional Investors Conference Transcript
Mar 04, 2019

MEDNAX Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2021 / 04:30PM GMT

Release Date Price: €24.8 (-0.80%)

Transcript

Jim Forbes

Good afternoon, and welcome to the Morgan Stanley Global Healthcare Conference. Pleased to have with us today the senior management team of MEDNAX. We've got Mark Ordan, the President and CEO; Jim Swift, the Executive Vice President, responsible for Corporate Development; and Charlie Lynch, EVP of Finance and Strategy.

We do have a disclaimer I have to read, and I will do that first. And I would also remind the audience that we have a Q&A portal. You can submit questions into the Q&A porta at any time. And so please do that.

The disclaimer, for important disclosures, please see the Morgan Stanley Research Disclosure Website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Mark, Jim, Charlie, thank you very much for participating in our conference. We've already got some questions. So I'm going to start off here.

Questions & Answers

Jim Forbes

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.